| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |